Abbott Laboratories is a globally diversified healthcare company founded in 1888. It is headquartered in Abbott Park, Illinois, and employs approximately 114,000 people worldwide. Abbott operates through four main segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. These segments collectively provide a broad and diversified line of healthcare products serving more than 160 countries.

The Established Pharmaceutical Products segment focuses on international sales of branded generic pharmaceutical products. The Diagnostic Products segment sells diagnostic systems and tests globally to blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment offers a wide range of adult and pediatric nutritional products worldwide, including well-known brands like Ensure and Similac. The Medical Devices segment covers products related to rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care.

Abbott has a strong global presence, generating about 70% of its revenue outside the United States and about half of its revenue from fast-growing markets. Its balanced diversity across product segments and geographies contributes to its resilience and growth prospects. The company is positioned to benefit from major healthcare trends such as the aging global population and the expansion of developing economies.

As a healthcare leader, Abbott is committed to innovation and consumer-facing healthcare solutions, with roughly 50% of sales directed to consumers and patients. The company aims to deliver top-tier growth, expanding margins, strong cash flow, and increasing returns to shareholders, building on more than 130 years of success.